INSIGHTS ON DRUG DEVELOPMENT
-
![peptides-preclinical-develop-GettyImages-2264393871]( "Screening For Amorphous Drug Substance")
Screening For Amorphous Drug SubstanceIncorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.
-
![GettyImages-1343695751-scanner-cost-pharma-medicine]( "Viral Gene Therapy: Reducing Costs To Improve Patient Access")
Viral Gene Therapy: Reducing Costs To Improve Patient AccessGene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.
-
![Deora_Nexa_]( "DEORA® : Filling The Gap For Multi-Use, Fixed-Dose Injection Solutions")
DEORA® : Filling The Gap For Multi-Use, Fixed-Dose Injection SolutionsHigh biologic demand requires delivery systems that balance simplicity with sustainability. Multi-use, fixed-dose platforms reduce waste, streamline workflows, and secure resilient supply chains.
-
![GettyImages-1269956871 vial bottle]( "Overcoming Challenges To High-Concentration Formulation Development")
Overcoming Challenges To High-Concentration Formulation DevelopmentExplore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.
-
High-Throughput Pyrogen Testing In A Multimode Microplate Reader3/20/2026
Explore a faster, high‑sensitivity approach to pyrogen detection that uses an NF‑κB reporter system to measure both endotoxin and non‑endotoxin contaminants to enable shorter workflows.
-
Your Guide To Precise And Robust Separation Methods11/12/2025
Discover a detailed guide to characterizing GLP-1 receptor agonists that covers advanced LC-MS and SEC-MALS workflows for impurity profiling, stability testing, and aggregate analysis.
-
Improving Stability Through Science-Led OSD Reformulation10/13/2026
A marketed multivitamin tablet spanning a 0.03% to 46% w/w range failed early in accelerated stability testing. Mechanism-led reformulation and a switch to direct compression changed the outcome.
-
Remote Measurements For Bulk Samples12/29/2025
Remote Raman spectroscopy enables accurate material identification at long distances without complex focusing. Learn how pathlength, sample properties, and substrate choice impact signal quality.
-
Efficient mAb Development With A Flexible Purification Toolkit6/4/2026
Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve target purity.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-155374807-molecule-molecular]( "Small Molecules Discovery")
Whether you require a particular expertise or a complete, experienced integrated small molecule discovery team, Curia can provide a high-performance solution to help turn your vision into reality.
-
![T-Cell-Kit-Ignite-Box-and-Vials-6ml]( "GenVoy-ILM™ T-Cell Kits For mRNA")
Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.
-
![GettyImages-2193981513-3d-molecular-structure]( "Patient-Derived Assay-Ready Organoids")
Gain human-relevant insights with patient-derived assay-ready organoids.
-
![GettyImages-950086574-microscope-scientist-pill-development]( "Developing Pediatric Formulations")
From safety considerations to kid-friendly dosing, we can help you get your pediatric formulation right.
-
![GettyImages-1187680243-biological-indicator-sterilization]( "Sterile Drug Product")
Accelerate sterile injectable development with expert support, advanced facilities, and tailored solutions for complex APIs — from formulation through commercialization across small molecules and biologics.
